Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

TA 993

Known as: TA-993 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
In the present study, we investigated the effects of TA-993 and its metabolite MB3 on platelet activation in vitro. TA-993 and… Expand
Is this relevant?
2001
2001
In the present study, we investigated the effects of the antiplatelet agent TA-993 and its metabolite MB3 on the hemorheological… Expand
Is this relevant?
2000
2000
We investigated the antiplatelet mechanisms of TA-993 [(-)-cis-3-acetoxy-5-(2-(dimethylamino)ethyl)-2, 3-dihydro-8-methyl-2-(4… Expand
Is this relevant?
2000
2000
TA-993 (cis-(-)-2-(4-methylphenyl)-3-acetoxy-2,3-dihydro-5-(2-dimethylaminoethy l)-8-methyl1,5-benzothiazepine-4(5H)-one maleate… Expand
Is this relevant?
1999
1999
TA-993, (-)-cis-3-acetoxy-5-(2-(dimethylamino)ethyl)-2, 3-di-hydro-8-methyl-2-(4-methylphenyl)-1,5-benzothiazepin-4(5H)one… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1998
1998
TA-993 is a new 1,5-benzothiazepine derivative having l-cis configuration and shows a potent antiplatelet aggregating action. We… Expand
Is this relevant?
1998
1998
TA-993 is a novel 1,5-benzothiazepine derivative of l-cis configuration, having a potent antiplatelet action and an increasing… Expand
Is this relevant?
1998
1998
TA-993, a new 1,5-benzothiazepine derivative having a l-cis configuration, has a selective increasing action on limb blood flow… Expand
Is this relevant?
1996
1996
TA-993, an l-cis 4',8-dimethyl derivative of the Ca2+ antagonist diltiazem, and some of its metabolites inhibited platelet… Expand
Is this relevant?
1995
1995
Since reported experimental models of thrombosis are not suitable for comparison of several drugs by oral administration, we… Expand
Is this relevant?